Scholars Central

Conference abstractPublished 15 Apr 2019

Using multiplex in situ hybridization and machine learning to evaluate bi-specific binder targets in metastatic Castration Resistant Prostate Cancer (mCRPC)

Authors: Michelle Callahan

Sanofi US, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biomarkers such as DNA, RNA and protein are powerful tools for understanding basic cellular functions, diagnosing clinical diseases and identifying optimal therapies. In particular, RNA is an ideal indicator of the dynamic gene expression changes that occur in an organism. RNAscope ® in situ hybridization assay, a novel technology established by Advanced Cell Diagnostics (California, USA), was utilized to generate RNA co-expression data to assist with prioritization of multi-antigen tumor targeting pairs. We developed a platform that allows binder pairs for a prostate-specific membrane antigen target to be evaluated for co-localization in tumor cells using fully automated multiplex in situ hybridization with immunohistochemistry on FFPE tissue. In conjunction with image acquisition and data analysis, imaging algorithms were developed to generate quantitative data for binder pairs colocalization, spatial distribution and proximity measurements within tumor and stromal architecture.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • SubjectOncology & Cancer
  • SubjectComputer Science & IT
  • SubjectEducation
  • BylineArticles whose byline prints “Michelle Callahan”